Anxiety and mood disorders and cannabis use

American Journal of Drug and Alcohol Abuse

Volumn 36, Issue 2, 2010, Pages 118-122

  Cheung, Joyce T W ^a   Mann, Robert E ^a,b   Ialomiteanu, Anca ^a   Stoduto, Gina ^a   Chan, Vincy ^a   Ala Leppilampi, Kari ^a   Rehm, Jürgen ^a,b  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Anxiety and mood disorder; Cannabis use; GHQ12; Population survey

Indexed keywords

CANNABIS;

ADULT; AGED; ALCOHOL CONSUMPTION; ANXIETY DISORDER; ARTICLE; DRUG ABUSE; DRUG WITHDRAWAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; RISK ASSESSMENT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANXIETY DISORDERS; COMORBIDITY; FEMALE; HEALTH SURVEYS; HUMANS; INTERVIEWS AS TOPIC; MALE; MARIJUANA ABUSE; MARIJUANA SMOKING; MIDDLE AGED; MOOD DISORDERS; ONTARIO; PREVALENCE; QUESTIONNAIRES; REGRESSION ANALYSIS; SEVERITY OF ILLNESS INDEX;

EID: 77950256134     PISSN: 00952990     EISSN: 10979891     Source Type: Journal    
DOI: 10.3109/00952991003713784     Document Type: Article

References (24)

1. Hall W, Degenhardt L, Maree T. Cannabis use and psychotic disorders update. Drug Alcohol Rev 2004; 23:433-443.
2. Degenhardt L, Hall W, Lynskey M. Exploring the association between cannabis use and depression. Addiction 2003; 98:1493-1504.
3. Alpert J, Maddocks A, Rosenbaum J, Fava M. Childhood psychopathology retrospectively assessed among adults with early onset depression. J Affect Disorders 1994; 31:165-171.
4. Troisi A, Pasini A, Saracco M, Spalletta G. Psychiatric symptoms in male cannabis users not using other illicit drugs. Addiction 1998; 93:487-492.
5. Kouri E, Pope H, Yurgelun-Todd D, Gruber S. Attributes of heavy vs. occasionalmarjiuana smokers in a college population. Bio Psychiatry 1995; 38:475-481.
6. Zvolensky M, Bernstein A, Sachs-Ericsson N, Schmidt NB, Buckner JD, Bonn-Miller MO. Lifetime associations between cannabis, use, abuse, and dependence and panic attacks in a representative sample. J Psychiat Res 2006; 40:477-486.
7. Moore THM, Zammit S, Lingford-HughesA, Barnes TRE, Jones PB, Burke M, Lewis G. Cannabis use and risk of psychotic or affective mental health outcomes: A systematic review. Lancet 2007; 370:319-328.
8. Ialomiteanu A, Adlaf EM. CAMH Monitor 2006: Technical Guide. Toronto: Centre for Addiction and Mental Health, 2007. Available at: http://www.camh.net/ research/areas of research/population life course studies/camh monitor/cm2006 techdoc.pdf. Accessed July 20, 2007.
9. Goldberg DP, Gater R, Sartorius N, Ustun TB, Piccinelli M, Gureje O, Rutter C. The validity of two versions of the GHQ in the WHO study of mental illness in general health care. Psychol Med 1997; 27;191-197.
10. Stoduto G, Dill P, Mann RE,Wells-Parker E, Toneatto T, Shuggi R. Examining the link between drinking driving and depressedmood. J StudAlcohol Drugs 2008; 69:777-780.
11. Mann RE, Asbridge M, Stoduto G, Smart RG, Goldbloom DS, Vingilis ER,Wickens CM. Psychological distress and collision involvement among adult drivers. Stress Health, in press. DOI: 10.1002/smi.1274.
12. Hardy GE, Shapiro DA, Havnes CE, Rick JE. Validation of the General Health Questionnaire-12 using a sample of employees from England's health care services. Psychol Assessment 1999; 11:159-165.
13. Bijl RV, Van Zessen G, Ravelli A, De Rilk C, Langendoen Y. The Netherlands Mental Health Survey and Incidence Study (NEMESIS): Objectives and design. Soc Psychiatry Psychiatric Epidem 1998; 33:581-586.
14. Mann RE, Cheung JTW, Ialomiteanu A, Stoduto G, Chan V,Wickens CM, Ala-leppilampi K, Goldbloom D, Rehm J. Estimating the prevalence of anxiety and mood disorder in survey data using the GHQ12: Exploration of threshold values. European J Psychiatry, submitted.
15. Rush B, Urbanoski K, Bassani D, Castel S, Wild TC, Strike C, Kimberley D, Somers J. Prevalence of co-occurring substance use and other mental disorders in the Canadian population. Can J Psychiatry 2008; 53:800-809.
16. Bijl RV, Ravelli A, Van Zessen G. Prevalence of psychiatric disorder in the general population: Results of the Netherlands Mental Health Survey and Incidence Study (NEMESIS). Soc Psychiatry Psychiatric Epidem 1998; 33:587-595.
17. Grant BF, Stinson FS, Dawson DA, Chou SP, Dufour MC, Compton W, Pickering RP, Kaplan K. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry 2004; 61(8):807-816.
18. Hasin DS, Stinson FS, Ogburn E, Grant BF. Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States. Arch Gen Psychiatry 2007; 64:830-842.
19. Saunders JB, Aasland OG, Babor TF, De la Fuente JR, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption. Addiction 1993; 88:791-804.
20. Chen C-Y, Wagner F, Anthony J. Marijuana use and the risk of major depressive episode: Epidemiological evidence from the United States National Comorbidity Survey. Soc Psychiatry Psychiatric Epidem 2002; 37:199-206.
21. Bovasso GB. Cannabis abuse as a risk factor for depressive symptoms. Am J Psychiatry 2001; 158:2033-2037.
22. Patton GC, Coffey C, Carlin JB, Degenhardt L, Lynskey M, Hall W. Cannabis use and mental health in young people: Cohort study. BMJ 2002; 325:1195-1198.
23. Aharonovich E, NguyenHT, Nunes EV. Anger and depressive states among treatment-seeking drug abusers: Testing the psychopharmacological specificity hypothesis. Am J Addict 2001; 10:327-334.
24. Degenhardt L, Hall W, LynskeyM. The relationship between cannabis use, depression and anxiety among Australian adults: Findings from the National Survey ofMental Health andWell-Being. Soc Psychiatry Psychiatric Epidem 2001; 36:219-227.